New York State Assembly

Bill No.:  

 
•  Summary 
 
•  Actions 
 
•  Committee Votes 
 
•  Floor Votes 
 
•  Memo 
 
•  Text 
 
•  LFIN 
 
•  Chamber Video/Transcript 

---

A07161 Summary:

BILL NO	A07161
SAME AS	SAME AS S01193
SPONSOR	Solages
COSPNSR
MLTSPNSR
Add 2404-e, Pub Health L
Ensures ovarian cancer survivors have the right to access screenings for health conditions.

Go to top    

---

A07161 Actions:

BILL NO	A07161
05/11/2023	referred to health
01/03/2024	referred to health

Go to top

---

A07161 Committee Votes:

Go to top

---

A07161 Floor Votes:

Go to top

---

A07161 Text:

 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          7161
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                      May 11, 2023
                                       ___________
 
        Introduced  by M. of A. SOLAGES -- read once and referred to the Commit-
          tee on Health
 
        AN ACT to amend the public health law, in relation to  ensuring  ovarian
          cancer survivors have the right to access screenings for health condi-
          tions
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The public health law is amended by adding  a  new  section
     2  2404-e to read as follows:
     3    §  2404-e.  Ovarian  cancer;  right  to  screenings.  No person with a
     4  personal history of ovarian cancer shall be denied  genetic  testing  or
     5  genomic  tumor  profiling  for inherited germline mutations and acquired
     6  somatic mutations, respectively. In general, such testing shall  not  be
     7  subject  to  frequency  caps or other limitations and shall include, but
     8  not be limited to:
     9    (a) genetic mutations in BRCA1 and BRCA2 genes;
    10    (b) genetic mutations associated with Lynch syndrome;
    11    (c) rearrangement analysis of all coding exons associated with ovarian
    12  cancer; and
    13    (d) additional mutations if medically necessary  and  appropriate,  as
    14  determined by the health care professional treating the individual.
    15    § 2. This act shall take effect immediately.
 
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02538-01-3

Go to top